Posts tagged as:

FBT

For Wall Street, the technology sector has been one of the most rewarding–yet frustrating–industries to invest in, as this corner of the market goes through periods of rapid revolutions, booms, and busts. But for those willing to stomach the risk, technology investments are some of the most promising, as developments made by these companies can impact a wide array of industries, making them more efficient and ultimately more profitable. The key to successfully capturing the industry’s success is to stay on top of all the latest tech news and developments, including even the more “far-fetched” innovations [see The Best (And Worst) Performing ETFs For Every Quarter]. [click to continue…]

{ Comments on this entry are closed }

While some American’s were elated with Obama’s re-election, Wall Street made it quite clear who it had voted for as markets took a sharp nosedive in a post-election sell off immediately following the President’s victory. To many investors, Obama’s re-election has placed looming concerns over the Fiscal Cliff to the forefront, as the automatic round of massive spending cuts and tax hikes now seem inevitable come January 1. And with Democrats maintaining control of the Senate and Republicans dominating the House, many remain understandably concerned about the split Congress coming up with a viable resolution [see 101 ETF Lessons Every Financial Advisor Should Learn]. [click to continue…]

{ Comments on this entry are closed }

When it comes to the world of exchange-traded products, there are virtually no limits as to how investors can choose to play nearly every corner of the market. From compelling quant-based methodologies to hyper-targeted sector funds, there is an ETF to fit essentially every investor’s investment objective. But for those looking to gain access to some of […]

{ Comments on this entry are closed }

The first half of 2012 is now in the books, dropping the curtain on a back-and-forth six months for many investors. Though the sentiment recently has been generally negative, the first half will close with positive year-to-date returns for many broad-based equity and bond ETFs–the result of a furious rally during the first two months […]

{ Comments on this entry are closed }

Last year was a good year for most asset classes, as investor portfolios continued to recover from the recent recession. The difference in performance between many comparable funds was significant, and many of the best performers of 2010 are relatively small funds that maintain considerably smaller asset bases than their more popular competitors. Below, we […]

{ Comments on this entry are closed }

Health care was once considered to be one of the most stable sectors of the U.S. economy, with demands for products and services fluctuating little during various phases of the economic cycle. But recent events in Washington have brought increased scrutiny and volatility, as the Obama administration’s health care reform has investors questioning the future […]

{ Comments on this entry are closed }

After sinking early in the week, equity markets finished on a high note with the Dow closing just below 11,000. Commodities have been in focus in recent trading, as oil sank for the week while gold soared as Greece’s credit rating was lowered to BBB-. In other news, Treasury Secretary Timothy Geithner visited Beijing in […]

{ Comments on this entry are closed }

ProShares, a leading provider of leveraged and inverse ETFs, announced the launch on Friday of the first ETFs with leveraged and inverse exposure to the biotechnology sector. The Ultra Nasdaq Biotechnology (BIB) will seek to provide 200% of the return on the NASDAQ Biotechnology Index for a single day. The UltraShort Nasdaq Biotechnology (BIS) will […]

{ Comments on this entry are closed }

As the array of ETF product offerings has expanded in recent years, the biotech space has seen significant activity. Currently, there are five biotech ETFs that have accumulated nearly $3.5 billion in aggregate assets. Each of these funds focuses on stocks in the biotechnology industry, and in many cases there is significant overlap between the […]

{ Comments on this entry are closed }

Which Biotech ETF Is Best For You?

by on February 9, 2010 | Updated April 29, 2013

As the ETF industry has grown by leaps and bounds in recent years, continued innovation has enabled investors to achieve more granular exposure than ever through exchange-traded products. Diversified ETFs targeting relatively narrow sectors of the domestic and global economy have multiplied, including funds targeting the airline, gaming, insurance, gold mining, timber, and food and […]

{ Comments on this entry are closed }

Best Performing ETFs Of 2009

by on December 21, 2009 | Updated April 30, 2010

Following a year that saw some of the worst performances in recent memory, many asset classes have bounced back in  2009. But some have performed better than others, and as the year draws to a close we take a look at some of the best-performing ETFs. The year’s top gainers include a few of the […]

{ Comments on this entry are closed }

Biotechnology ETFs enjoyed bug jumps at the beginning of this week, thanks primarily to a huge increase in the stock price of a key component of several funds. Human Genome Sciences Inc. (HGSI) has jumped more than 450% over the last week on news that its lupus drug Benlysta showed late-stage success in a clinical […]

{ Comments on this entry are closed }